(Q83135082)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Phase I trial of TGF-beta 2 antisense GM-CSF gene-modified autologous tumor cell (TAG) vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

main subject

phase I clinical trial

1 reference

13

John Nemunaitis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Jairo Olivares

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Padmasini Kumar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Yang Yu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Phillip B Maples

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Neil Senzer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Cynthia Bedell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Minal Barve

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Alex Tong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Beena O Pappen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Joseph Kuhn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mitchell Magee

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Gladice Wallraven

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

183-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

Immunotherapy for advanced renal cell cancer

19 January 2020

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001425.PUB2

Identifiers

DOI

10.1158/1078-0432.CCR-10-2195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21208907%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference